Stock listing

ALVIO Stock Price, News, Filings & Events — Valerio Therapeutics

Selected listing: ALVIO · EURONEXT · EUR · FR

This page tracks Valerio Therapeutics's ALVIO:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALVIO:EURONEXT. ALVIO:EURONEXT is the stock-level entry point for investors researching Valerio Therapeutics, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Valerio Therapeutics is a public company traded under the ticker ALVIO on the French market. The company has a market capitalization of approximately €353.9 million. Valerio Therapeutics focuses on developing innovative therapeutic solutions.

ALVIO:EURONEXTEURFRUpdated August 14, 2026
Valerio Therapeutics logo
Ticker
ALVIO:EURONEXT
Asset type
Stock
Market cap
$437.4M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
EURONEXT
Currency
EUR

Valerio Therapeutics ALVIO:EURONEXT stock context

This page tracks Valerio Therapeutics's ALVIO:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALVIO:EURONEXT. ALVIO:EURONEXT is the stock-level entry point for investors researching Valerio Therapeutics, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Valerio Therapeutics is a public company traded under the ticker ALVIO on the French market. The company has a market capitalization of approximately €353.9 million. Valerio Therapeutics focuses on developing innovative therapeutic solutions.

Research Valerio Therapeutics

Alternate listings